Kairos Pharma enters two service agreements: $615K cash + 50K RSUs

Kairos Pharma, LTD.

CEO.CA Technologies to provide advertising and consulting for $250,000 over 12 months.
Belair Capital Advisors to provide strategic advisory for $365,000 plus 50,000 RSUs vesting in 6 months.
Services include digital marketing, market research, business development assistance, and stakeholder communication.
Both agreements are governed by Ontario law and contain standard indemnification clauses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.